Puma biotech Inc Live Stock Price Today, Share Analysis and Chart

Name: Puma Biotechnology Inc: Is Infosys Ltd. worth buying?
Item: Puma Biotechnology Inc
Rating: 2.267805625
Author: Trendlyne DVM scores

Mid-range Performer

about

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

5.96 -0.04 (-0.67%)

131.01% Gain from 52W Low

65,484.2

XNAS Volume

XNAS 12 Mar, 2026 12:05 PM (EDT)

Medium Financial Strength

38.9 / 100

Affordable Valuation

54.2 / 100

Technically Neutral

49.5 / 100

Mid-range Performer These stocks have affordable valuations, but mid range financials and momentum View Similar Embed DVM

1Yr Price target downside is -16%

1 analysts

Puma biotech Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Puma biotech Inc Live Stock Price Today, Share Analysis and Chart

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

131.01% Gain from 52W Low

SWOT Analysis

Puma biotech Inc Live Price Chart